Opus Genetics Inc Live Stock Price Today, Share Analysis and Chart

Name: Opus Genetics Inc.: Is Infosys Ltd. worth buying?
Item: Opus Genetics Inc.
Rating: 1.90775
Author: Trendlyne DVM scores

about

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline include...

5.36 0.10 (1.90%)

495.56% Gain from 52W Low

1.2M

XNAS Volume

XNAS 07 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Opus Genetics Inc is on 15 May 2026 for the purpose of Opus Genetics Inc First Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

5.5 / 100

Technically Bullish

70.8 / 100

1Yr Price target upside is 89%

15 analysts

Opus Genetics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Opus Genetics Inc Live Stock Price Today, Share Analysis and Chart

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline include...

495.56% Gain from 52W Low

SWOT Analysis

Opus Genetics Inc Live Price Chart